Trial search
Nation, Province(City)
Code of disease
Primary sponsor(s)
Secondary sponsor(s)
Funding source
Recruiting status
Register status
Measure
Ethical committee
Study type
Anlotinib and bermosubamab were provided free of charge by Chia Tai Tianqing Company
Check the details 1(7.69%)Shenzhen Medical Key Cultivation Discipline (The University of Hong Kong Shenzhen Hospital Supporting Construction Fund)
Check the details 1(7.69%)This project is supported by the National Key Science and Technology Program for the Prevention and Control of Cancer, Cardiovascular and Cerebrovascular Diseases, Respiratory Diseases, and Metabolic Diseases (Grant No. 2024ZD0527905; Principal Investigator: Wenjie Zi), and the National Science Fund for Distinguished Young Scholars (Clinical Science) (Grant No. 82425021; Principal Investigator: Wenjie Zi).
Check the details 1(7.69%)
Chinese Clinical Trial Registry, Primary Registry of WHO International Clinical Trials Registry Platform
Copyright(c) (2005 - 2023) Chictr.org.cn.All rights reserved. Chinese Clinical Trial Registry
Note: It is recommended to use the widescreen display resolution of Internet Explorer 8.0 or later